Lupin inks pact with Exeltis to promote Solosec Drug in US
Synopsis: Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat…
Synopsis: Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat…
Summary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives…
Synopsis- Aptar Pharma and i2c Pharmaceutical Services joins hand for co-develop and promote i2c’s pressurized metered dose inhaler (pMDI) technology, Respitab.…